US Stock MarketDetailed Quotes
RCKT Rocket Pharmaceuticals
- 12.930
- -0.110-0.84%
Trading Nov 21 11:17 ET
1.18BMarket Cap-4736P/E (TTM)
13.150High12.660Low223.80KVolume13.130Open13.040Pre Close2.89MTurnover0.32%Turnover RatioLossP/E (Static)91.16MShares32.52552wk High3.57P/B918.91MFloat Cap12.62052wk Low--Dividend TTM71.07MShs Float67.480Historical High--Div YieldTTM3.76%Amplitude7.565Historical Low12.900Avg Price1Lot Size
About Rocket Pharmaceuticals Company
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Company Profile
SymbolRCKT
Company NameRocket Pharmaceuticals
Listing DateFeb 18, 2015
Issue Price6.00
Founded1999
CEODr. Gaurav Shah, M.D.
MarketNASDAQ
Employees268
Fiscal Year Ends12-31
Address9 Cedarbrook Drive
CityCranbury
ProvinceNew Jersey
CountryUnited States of America
Zip Code08512
Phone1-609-659-8001
Websitehttp://www.rocketpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Gaurav Shah, M.D.
- Director and Chief Executive Officer
- 8.01M
- Raj Prabhakar
- Chief Business Officer and Senior Vice President
- --
- Aaron Ondrey
- Chief Financial Officer
- --
- Jonathan Schwartz, M.D.
- Chief Medical Officer and Chief Gene Therapy Officer
- 3.16M
- Dr. Kinnari Patel, M.B.A.,Pharm.D.
- President, Chief Operating Officer and Head of R&D
- 4.85M
- Martin Wilson, J.D.
- Chief Corporate Officer, Senior Vice President, General Counsel and Chief Compliance Officer
- --
- Mayo Pujols
- Chief Technical Officer and Executive Vice President
- 4.38M
- Mark White
- General Manager, Commercial Affairs
- --
- John Militello, C.P.A.
- Vice President, Finance, Senior Controller, Treasurer and Principal Accounting Officer
- 1.53M
- Dr. Roderick Wong, M.D.
- Chairman of the Board
- 409.99K
- Dr. Mikael Dolsten, M.D.
- Director
- --
- David P. Southwell
- Independent Director
- 399.99K
- Dr. Gotham Makker, M.D.
- Independent Director
- 399.99K
- Dr. Elisabeth Bjork, M.D.,PhD
- Independent Director
- 409.99K
- Carsten Boess
- Independent Director
- 427.49K
- Dr. Naveen Yalamanchi, M.D.
- Independent Director
- 417.49K
- Dr. Fady Ibraham Malik, M.D.,PhD
- Independent Director
- 399.99K
- Pedro P. Granadillo
- Independent Director
- 429.98K
- Robert Keith Woods
- Independent Director
- 568.70K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data